Medical Doctor Program year 2019 Source: CMS Open Payments, 2026 publication

Francine Cormier

Adolescent Medicine Poughkeepsie, NY Medical Doctor

NPI 1164432563 CMS profile 453415

2507 South Rd, Poughkeepsie, NY 12601

Open in the dashboard

General payments

$111

1 record reported · program year 2019

Research payments

$0

Paid to them · None reported · program year 2019

Ownership & investment interest

$0

None reported

Through program year 2019, Francine Cormier of Poughkeepsie, NY is reported in the CMS Open Payments database as having received $111 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2019 General $111 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Francine Cormier
  • Adolescent Medicine median
  • Middle half of Adolescent Medicine
  • National median

In program year 2025, general payments to Francine Cormier were reported at $0. Among 40 Adolescent Medicine profiles paid that year, the median was $135 and the middle half received between $78 and $573.

Show as a table
Year Francine Cormier Adolescent Medicine median Middle half National median
2019 $111 $112 $24–$444 $163
2020 $0 $80 $35–$250 $114
2021 $0 $229 $55–$448 $132
2022 $0 $162 $35–$492 $149
2023 $0 $182 $54–$507 $160
2024 $0 $142 $59–$362 $164
2025 $0 $135 $78–$573 $169

Breakdown

Who paid General payments · program year 2019
  1. AbbVie, Inc. $111 1 payment

Every payment, record by record

What the payments were for General payments · program year 2019
  1. Food and Beverage $111 1 payment
Products named General payments · program year 2019
  1. Orilissa $111 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

175

Median for Family Practice: 1,826

Drug cost

$1,295

Median for Family Practice: $120,094

Branded share of claims

0%

Median for Family Practice: 18.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Metoprolol Succinate Generic 15 $367
Atorvastatin Calcium Generic 49 $325
Levothyroxine Sodium Generic 13 $164
Amlodipine Besylate Generic 30 $162
Lisinopril Generic 28 $144
Pravastatin Sodium Generic 11 $70
Hydrochlorothiazide Generic 13 $34
Metoprolol Tartrate Generic 16 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$9,737

Medicare's payments for the services billed

Medicare patients

113

Average age 74

Services billed

225

79 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 53%
Ischemic heart disease 30%
Chronic kidney disease 29%
Diabetes 27%
COPD 24%
Cancer 21%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adolescent Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2019

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record